Lite Strategy Inc (LITS) Stock Price, Quote & News

Company Profile

Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.

Industry: Biotechnology

Sector: Healthcare

Phone: 858 369 7100

Website: www.litestrategy.com

Address:

9920 Pacific Heights Blvd., Suite 150, San Diego, United States

CopyCatInvestmentCorp Jul. 1 at 9:15 PM

$LITS $BCHG 👀 See you in 2027 before halving 💰😇

0 · Reply

s3v3nSph3r3 Jun. 30 at 4:00 PM

$LITS Possible last drop in LTC! This is the setup the market is giving me right now. I closed all my lits position and ill open some after the drop. Look for divergence when you want to enter again. Happy Trading!

0 · Reply

s3v3nSph3r3 Jun. 28 at 8:14 AM

$LITS I think the drop is far from over . More and more people say publicly that $MSTR is a ponzi scheme company. Those posts are going virals.

0 · Reply

s3v3nSph3r3 Jun. 26 at 6:00 PM

$LITS don't forget your hedge

0 · Reply

s3v3nSph3r3 Jun. 26 at 4:39 PM

$LITS im sorry to hurt the LITS holder who truly believe in LTC. I love them and the LTC community but i hate that management team. But take an edge with Wendy and you wont care if LITS goes dows in the next week.

0 · Reply

R3JS Jun. 26 at 4:33 PM

$LTC.X $LITS lits is up 8%

2 · Reply

s3v3nSph3r3 Jun. 26 at 4:19 PM

$LITS buying to protect your asset at 0.882$. 🤔 When BTC goes under 50k because it will, you will regret those buys 😅 This is why i will never buy at those price or higher. I would buy LTCN or LTCC but never LITS. To buy LITS it need to be undervalue alot because of the management Teams. We need a good protection in price against them 😅 Like when LTC was 43 and LITS at 0,70 is was a buy but now its a hold or sell. Im taking about Guiness Record of money destruction for the biggest company holding LTC. Seem like a setup for something else...

0 · Reply

s3v3nSph3r3 Jun. 26 at 3:53 PM

$LITS +6% when LTC is going down on a volume of 79K . I would not hire that CEO to run a 7/11 because it would go bankrupt. People won't buy in at those prices. Better with $WEN . DEEP ..... VALUE!! The expansion of 2000 restaurants Worldwide is coming. ♦️🙌♦️

0 · Reply

s3v3nSph3r3 Jun. 26 at 3:16 PM

$LITS At this price, buy LTCN if you cant stop yourself from buying. At least the NAV give you so much better for your money. LITS right now is not overvalue but its far from undervalue. Its fair value... While LTCN is the right bet right now. But LTC will drop with BTC no matter what so dont buy :D

0 · Reply

s3v3nSph3r3 Jun. 25 at 2:35 PM

$LITS Don't lose all your money in $LITS. $WEN is making a monthly bottom. Record volume EVER. ♦️🙌♦️ buying

0 · Reply

Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam

LTC

2026-06-18T12:48:16.000Z - 16 days ago

Lite Strategy leads strategic investment in LitVM

Jun 18, 2026, 8:30 AM EDT - 16 days ago

Lite Strategy Leads Strategic Investment in LitVM

May 13, 2026, 8:30 AM EDT - 7 weeks ago

Lite Strategy Reports Fiscal 2026 Third Quarter Results

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Lite Strategy Quarterly report: Q3 2026

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Lite Strategy Earnings release: Q3 2026

2026-02-17T14:40:22.000Z - 4 months ago

Lite Strategy reports Q2 EPS (82c) vs. (40c) last year

2026-02-17T14:00:57.000Z - 4 months ago

Lite Strategy to continue to evaluate strategic investments in 2H of 2026

Feb 17, 2026, 8:50 AM EST - 4 months ago

Lite Strategy Reports Fiscal 2026 Second Quarter Results

Feb 17, 2026, 7:00 AM EST - 4 months ago

Lite Strategy Earnings release: Q2 2026

Feb 17, 2026, 7:00 AM EST - 4 months ago

Lite Strategy Quarterly report: Q2 2026

Jan 27, 2026, 7:00 AM EST - 5 months ago

Lite Strategy Proxy statement: Proxy Filing

Dec 30, 2025, 7:00 AM EST - 6 months ago

Lite Strategy Proxy statement: Proxy Filing

Dec 30, 2025, 7:00 AM EST - 6 months ago

Lite Strategy Proxy statement: Proxy Filing

2025-11-19T16:15:44.000Z - 8 months ago

Lite Strategy names acting CEO Justin File to role on a permanent basis

2025-11-17T14:05:45.000Z - 8 months ago

Lite Strategy reports Q1 results, highlights launch of $100M Litecoin Treasury

Nov 14, 2025, 4:00 PM EST - 8 months ago

Lite Strategy Quarterly report: Q1 2026

2025-10-29T13:12:45.000Z - 8 months ago

Lite Strategy announces $25M share repurchase program

2025-10-08T20:50:10.000Z - 9 months ago

Lite Strategy files to sell 780,497 shares of common stock for holders

Oct 8, 2025, 8:00 AM EDT - 9 months ago

Lite Strategy Registration statement: Registration Filing

Sep 26, 2025, 7:00 AM EDT - 10 months ago

Lite Strategy Annual report: Q4 2025

Sep 10, 2025, 9:00 AM EDT - 10 months ago

MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS'

Aug 26, 2025, 8:00 AM EDT - 11 months ago

Lite Strategy Registration statement: Registration Filing

Aug 6, 2025, 8:00 AM EDT - 11 months ago

Lite Strategy Registration statement: Registration Filing

Aug 5, 2025, 8:00 AM EDT - 11 months ago

MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising

Jul 24, 2025, 8:00 PM EDT - 1 year ago

BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode

Jul 22, 2025, 4:35 PM EDT - 1 year ago

MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

Jul 18, 2025, 8:30 AM EDT - 1 year ago

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange

May 13, 2025, 4:05 PM EDT - 1 year ago

MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position

May 13, 2025, 4:00 PM EDT - 1 year ago

Lite Strategy Earnings release: Q3 2025

May 13, 2025, 4:00 PM EDT - 1 year ago

Lite Strategy Quarterly report: Q3 2025

Feb 12, 2025, 4:12 PM EST - 1 year ago

MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position

Feb 12, 2025, 12:00 AM EST - 1 year ago

Lite Strategy Earnings release: Q2 2025

Feb 12, 2025, 12:00 AM EST - 1 year ago

Lite Strategy Quarterly report: Q2 2025

Dec 20, 2024, 7:00 AM EST - 1 year ago

Lite Strategy Proxy statement: Proxy Filing

Dec 20, 2024, 7:00 AM EST - 1 year ago

Lite Strategy Proxy statement: Proxy Filing

Nov 12, 2024, 4:05 PM EST - 1 year ago

MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position

Nov 12, 2024, 4:00 PM EST - 1 year ago

Lite Strategy Earnings release: Q1 2025

Nov 12, 2024, 4:00 PM EST - 1 year ago

Lite Strategy Quarterly report: Q1 2025

Sep 19, 2024, 4:01 PM EDT - 1 year ago

MEI Pharma Reports Fiscal Year End 2024 Cash Position

Sep 18, 2024, 6:00 PM EDT - 1 year ago

Lite Strategy Earnings release: Q4 2024

Sep 18, 2024, 6:00 PM EDT - 1 year ago

Lite Strategy Annual report: Q4 2024

Aug 12, 2024, 8:30 AM EDT - 2 years ago

MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives

Jul 22, 2024, 8:30 AM EDT - 2 years ago

MEI Pharma to Consider Strategic Alternatives

May 9, 2024, 4:02 PM EDT - 2 years ago

MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

May 9, 2024, 4:00 PM EDT - 2 years ago

Lite Strategy Quarterly report: Q3 2024

May 9, 2024, 4:00 PM EDT - 2 years ago

Lite Strategy Earnings release: Q3 2024

Apr 16, 2024, 1:30 PM EDT - 2 years ago

Lite Strategy Transcript: Stifel Virtual Targeted Oncology Days Conference

Apr 11, 2024, 8:02 AM EDT - 2 years ago

MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344

Apr 11, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients

Apr 10, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum

$MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia$

Mar 26, 2024, 8:00 AM EDT - 2 years ago

MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia

Feb 20, 2024, 7:00 AM EST - 2 years ago

Lite Strategy Registration statement: Registration Filing

Feb 13, 2024, 5:05 PM EST - 2 years ago

MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Feb 13, 2024, 4:00 PM EST - 2 years ago

Lite Strategy Quarterly report: Q2 2024

Feb 13, 2024, 4:00 PM EST - 2 years ago

Lite Strategy Earnings release: Q2 2024

Jan 16, 2024, 5:00 PM EST - 2 years ago

MEI Pharma to Present Design of Ongoing Clinical Study Evaluating ME-344 at ASCO GI Cancers Symposium 2024

Dec 11, 2023, 12:00 PM EST - 2 years ago

MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023

Nov 15, 2023, 8:35 AM EST - 2 years ago

Lite Strategy Transcript: The Stifel 2023 Annual Healthcare Conference

Nov 9, 2023, 4:05 PM EST - 2 years ago

MEI Pharma Reports First Quarter Fiscal Year 2024 Results and Operational Highlights

Nov 9, 2023, 4:00 PM EST - 2 years ago

Lite Strategy Quarterly report: Q1 2024

Nov 9, 2023, 4:00 PM EST - 2 years ago

Lite Strategy Earnings release: Q1 2024

Nov 8, 2023, 8:00 AM EST - 2 years ago

MEI Pharma to Present at the Stifel 2023 Healthcare Conference

Nov 8, 2023, 7:00 AM EST - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Nov 8, 2023, 7:00 AM EST - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Nov 6, 2023, 4:57 PM EST - 2 years ago

MEI Pharma Declares Special Cash Dividend of $1.75 Per Share of Common Stock

Nov 2, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Announces Acceptance of Abstract for Presentation at ASH 2023

Nov 1, 2023, 9:00 AM EDT - 2 years ago

MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

Nov 1, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Oct 18, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Oct 17, 2023, 5:33 PM EDT - 2 years ago

MEI Pharma Recommends Stockholders Not to Consent

Oct 17, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Oct 12, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Oct 10, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Oct 2, 2023, 8:00 AM EDT - 2 years ago

Lite Strategy Proxy statement: Proxy Filing

Oct 2, 2023, 6:00 AM EDT - 2 years ago

MEI Pharma Adopts Limited-Duration Stockholder Rights Plan

Sep 29, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Sep 28, 2023, 5:00 PM EDT - 3 years ago

MEI Pharma Issues Statement Regarding Anson and Cable Car's Opportunistic Actions

Sep 28, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Sep 28, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Sep 26, 2023, 5:00 PM EDT - 3 years ago

Lite Strategy Earnings Call Transcript: Q4 2023

Sep 26, 2023, 5:00 PM EDT - 3 years ago

Lite Strategy Annual report: Q4 2023

Sep 26, 2023, 5:00 PM EDT - 3 years ago

Lite Strategy Earnings release: Q4 2023

Sep 26, 2023, 4:02 PM EDT - 3 years ago

MEI Pharma Reports Fiscal Year 2023 Results and Operational Highlights

Sep 26, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Sep 21, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma to Report 2023 Fiscal Year End Financial Results and Provide Corporate Overview on September 26, 2023

Sep 18, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Confirms Receipt of Director Nominations From Anson and Cable Car

Sep 18, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Sep 15, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Aug 16, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer

Jul 23, 2023, 2:30 PM EDT - 3 years ago

MEI Pharma Announces Results of Special Meeting of Stockholders

Jul 19, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction

Jul 18, 2023, 9:00 AM EDT - 3 years ago

MEI Pharma Responds to Anson and Cable Car

Jul 17, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Encourages Shareholders to Vote FOR the Infinity Transaction

Jul 17, 2023, 8:00 AM EDT - 3 years ago

Lite Strategy Proxy statement: Proxy Filing

Jul 13, 2023, 4:05 PM EDT - 3 years ago

MEI Pharma Postpones Special Meeting of Shareholders

Jul 11, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals

Jul 7, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Reminds Shareholders to Vote FOR the Merger with Infinity Pharmaceuticals

Jul 5, 2023, 8:30 AM EDT - 3 years ago

ISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.

Jul 5, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Highlights Recommendation by Leading Independent Proxy Advisory Firm ISS to Vote “FOR” Pending Transaction with Infinity Pharmaceuticals

Jun 29, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Mails Letter to Shareholders Reiterating Value Creating Potential of Proposed Transaction with Infinity Pharmaceuticals

Jun 15, 2023, 12:08 PM EDT - 3 years ago

MEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology Candidates

Jun 14, 2023, 7:01 PM EDT - 3 years ago

INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI

Jun 13, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Planned Departure of Chief Financial Officer Brian Drazba and Appointment of Justin File as Successor

Jun 2, 2023, 8:00 AM EDT - 3 years ago

MEI Pharma Announces Planned Departure of CEO Daniel P. Gold, Ph.D.

CopyCatInvestmentCorp Jul. 1 at 9:15 PM

$LITS $BCHG 👀 See you in 2027 before halving 💰😇

0 · Reply

s3v3nSph3r3 Jun. 30 at 4:00 PM

0 · Reply

s3v3nSph3r3 Jun. 28 at 8:14 AM

$LITS I think the drop is far from over . More and more people say publicly that $MSTR is a ponzi scheme company. Those posts are going virals.

0 · Reply

s3v3nSph3r3 Jun. 26 at 6:00 PM

$LITS don't forget your hedge

0 · Reply

s3v3nSph3r3 Jun. 26 at 4:39 PM

0 · Reply

R3JS Jun. 26 at 4:33 PM

$LTC.X $LITS lits is up 8%

2 · Reply

s3v3nSph3r3 Jun. 26 at 4:19 PM

0 · Reply

s3v3nSph3r3 Jun. 26 at 3:53 PM

0 · Reply

s3v3nSph3r3 Jun. 26 at 3:16 PM

0 · Reply

s3v3nSph3r3 Jun. 25 at 2:35 PM

$LITS Don't lose all your money in $LITS. $WEN is making a monthly bottom. Record volume EVER. ♦️🙌♦️ buying

0 · Reply

s3v3nSph3r3 Jun. 25 at 5:19 AM

$LITS Are you paying too much for your shares based on NAV during a LTC drop? If LTC drop by 10%,20%,30%,... from here , it's good to know exactly the discount you based on the NAV price. Are you getting a good deal? The NAV as today is 1.18$. This is the chart i use.

0 · Reply

s3v3nSph3r3 Jun. 25 at 2:41 AM

$LITS We need to get rid of that CEO like $WEN did. Then we can go up 🚀 While you wait, the ♦️🙌♦️will Save Wendy's.

0 · Reply

s3v3nSph3r3 Jun. 25 at 1:46 AM

$MSTR MSTR currently has an unrealized loss of $12.5 billion, surpassing the largest trading loss in history (Bill Hwang/Archegos) by $2.5 billion. But it wont affect LTC or his copy company $LITS . 😇

0 · Reply

s3v3nSph3r3 Jun. 24 at 7:00 PM

$LITS Very soon that company will be so much overvalue compared to the price of LTC. It was undervalue when LTC was at 43 and the stock was at 0.70$. But now the price to book goes so high that you should buy LTC instead of $LITS. Some people holding right now will take a hit of over 60% i the coming weeks :D Watch out at this price, LITS is overvalue. Insvest in LTC directly if you are bullish.. But if you buy at 40$ expect losing 50% in the next weeks :D

0 · Reply

s3v3nSph3r3 Jun. 24 at 3:48 PM

$LITS Sell Mortimer Sell!! 😅

0 · Reply

s3v3nSph3r3 Jun. 24 at 3:09 AM

$LITS Sold another 5K $LITS today. And i unloaded 222 LTC that i hold on a wallet since 2021 or 5 years. I still own alot but it worth noticing when a real diamond hands sell. LTC ♦️🙌♦️wallet as proof: LT4eDAiEPs8jAuCaPLk4JYdC2B1W8hvgdg I hope it goes up because im still loaded but i wanted to have some munition to buy more lower. As i said be ready to buy LTC near 20$ like Charlee said. And let me tell you something about that CEO, he's not good!! I rided the GameStop run with the ♦️🙌♦️but never the CEO of Gamestop acted retarded like him investing 1M in BS instead of buying its own stock like he have said. Without that litVM scam the stock could had hold 0.70$ even at LTC 25$ but now forget about it :(

0 · Reply

s3v3nSph3r3 Jun. 21 at 5:46 PM

$LITS That CEO is paid 1M per year for a 25M MC company. He spends 1M on things that will exist no matter what but has no real value at that exact moment, so certainly not 1M. I expect LTC to go in the twenty like Charlee Lee said years ago. Still huge wall forming against LTC. Can $LITS drop more than 50% again from that bad LitVM money burning news if BTC goes to 52k-50k again. Yes, and the CEO will take 1M anyway even if the MC is worth 10M after that

0 · Reply

focafoca99 Jun. 19 at 12:51 PM

$LITS is attending a panel at the Litecoin Foundation Summit in Amsterdam on June 22.

0 · Reply

s3v3nSph3r3 Jun. 18 at 7:39 PM

$LITS will we get a friday market open of -25% if ltc goes to 41$ or under on $LITS ? For sure!!! it would had been so much better without that bad news from today presented like a beautiful girl but in fact it was a girl but not a born girl idk how to say it correctly.. I need to say that it can go to 0.45$ or 50% from 0.92 when they annonced the news. GG management team, now i begin to understand what the shareholder of your pharma company was thinking

0 · Reply

CashCow11 Jun. 18 at 7:38 PM

$LITS bankruptcy soon. Investing in Litvm was the stupidest idea ever when you are not a profitable company. Just fattening each other's pockets

0 · Reply

s3v3nSph3r3 Jun. 18 at 7:08 PM

$LITS Just sold 5k share at 0.84$ still own a bunch and planning to add more when the litvm lemming finally say it was a mistake.. under 0.70$ :) i hope it will reverse up but the odds are with me :) ♦️🙌♦️

0 · Reply

s3v3nSph3r3 Jun. 18 at 6:51 PM

$LITS Keep some cash to add under 0.70$ because people who wanted that company to invest 1M in litvm does not have the cash to support the price of the stock at that price. ♦️🙌♦️

0 · Reply

Market Cap	32.34M
Revenue (ttm)	0.00
Net Income (ttm)	-15.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	189,400
Avg Vol	438,988
Day's Range	N/A - N/A
Shares Out	34.03M
Stochastic %K	74%
Beta	0.21
Analysts	Hold
Price Target	N/A